J. Vaage

Molecular Cloning of the cDNA Encoding pp36, a Tyrosine-phosphorylated Adaptor Protein Selectively Expressed by T Cells and Natural Killer Cells

J. Imboden, K. Torgersen, K. Taskén, 1998, The Journal of experimental medicine.

T cell responses to SARS-CoV-2 vaccination in people with multiple sclerosis differ between disease-modifying therapies

F. Lund-Johansen, G. Nygaard, H. Harbo, 2022, medRxiv.

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study

F. Lund-Johansen, A. Tveter, H. Kared, 2024, Frontiers in immunology.

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients

F. Lund-Johansen, K. Midtvedt, A. Reisæter, 2023, EBioMedicine.

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study

A. Tveter, G. Goll, E. Haavardsholm, 2024, RMD open.

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy

J. Jahnsen, A. Tveter, A. Chopra, 2022, RMD Open.

Multiplexed measurement of binding- and neutralizing antibodies to SARS-CoV-2 variants in 12.000 post-vaccine sera

F. Lund-Johansen, P. Magnus, E. Melum, 2022 .

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination

F. Lund-Johansen, Simen Tennøe, R. Stratford, 2024, Frontiers in immunology.